Correlation of visfatin level with non-alcoholic fatty liver in metabolic syndrome
نویسندگان
چکیده مقاله:
Background: Metabolic syndrome (MS) and non-alcoholic fatty liver disease (NAFLD) is a common public health problem. Visfatin is secreted by visceral adipose tissue and is an adipocytokine. It could be a pro-inflammatory adipocytokine and is related to the metabolic syndrome and non-alcoholic fatty liver disease. This study evaluated the association between visfatin levels in patients with the metabolic syndrome with and without non-alcoholic fatty liver disease (NAFLD). Methods: In this cross-sectional study, 120 patients with metabolic syndrome were selected. They were categorized into two groups, patients with fatty liver (n=70) and without fatty liver disease (n=50). Laboratory and anthropometric options such as age, sex, systolic blood pressure, fasting blood sugar, lipid profile, liver enzymes, uric acid, visfatin, insulin, BMI, waist circumference, and TNF-α were measured. The chi-square test, Mann-Whitney, t test, Spearman and Pearson correlations were used for the data analysis. Results: There was a significant difference between the fatty liver and non-fatty liver disease with visfatin, BMI, FBS and lipid profile (p<0.05). The mean±SD level of visfatin was 37.1±1.7 ng/dl in the non-fatty liver and was 44.4±1.5 ng/dl in fatty liver participants (p=0.02). 59% of patients with metabolic syndrome had fatty liver in ultrasonography. Conclusion: According to this study, there was a correlation between visfatin levels and fatty liver disease.
منابع مشابه
Association of lifestyle with metabolic syndrome and non-Alcoholic fatty liver in children and adolescence
Introduction: Identification of the factors related to non-alcoholic fatty liver disease in children and adolescents help us to know appropriate methods for prevention and control of chronic diseases. Methods: This cross-sectional and analytic study comprised 962 children and adolescents, aged 6-18 years, in Isfahan in 2008. Variables related to life style and metabolic syndromes related...
متن کاملMetabolic syndrome and non-alcoholic fatty liver disease
Manuscript received and accepted: 26 September 2008 Abstract The development of nonalcoholic fatty liver disease (NAFLD) is strongly associated with the metabolic syndrome as reflected by the fact that approximately 90% of the patients with NAFLD have more than one feature of metabolic syndrome and about 33% have three or more criteria. The physiopathology, epidemiology and therapeutic consider...
متن کاملiron status and metabolic syndrome in patients with non-alcoholic fatty liver disease
background: a hypothesis has been presented about the role of serum iron, ferritin and transferrin saturation among patients with non-alcoholic fatty liver disease (nafld) and resistance to insulin (metabolic syndrome [mets]), but there is much controversy. this study aimed at investigating the level of serum iron and demographic characteristics in patients with nafld with or without mets. meth...
متن کاملnon-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings
متن کامل
Statins for the Treatment of Non Alcoholic Fatty Liver Disease in Patients with Metabolic Syndrome
Submit Manuscript | http://medcraveonline.com obesity, metabolic syndrome (MetS) or type 2 diabetes mellitus (T2DM). Histological manifestations of NAFLD vary from isolated steatosis to steatohepatitis (NASH), which is characterized by liver necroinflammation and ballooning with or without liver fibrosis, and finally cirrhosis; in some cases NASH may progress to hepatocellular carcinoma [4]. Da...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ذخیره در منابع من قبلا به منابع من ذحیره شده{@ msg_add @}
عنوان ژورنال
دوره 31 شماره 1
صفحات 167- 170
تاریخ انتشار 2017-01
با دنبال کردن یک ژورنال هنگامی که شماره جدید این ژورنال منتشر می شود به شما از طریق ایمیل اطلاع داده می شود.
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023